Medical Countermeasures

Agenda for Meeting Eleven: November 5-6, 2012 in Chicago, IL

Divinity School, The University of Chicago
1025 E. 58th St. Chicago, IL 60637

Monday, November 5

9:00 – 9:15 a.m.  Welcome and Opening Remarks

Transcript, Meeting 10, Session 11

SESSION 11: ROUNDTABLE DISCUSSION

DR. GUTMANN:  Thank you all for giving us such stimulating presentations.  And this is an opportunity for us to pick your brains one more time, and it's become a tradition to begin with a question of asking you to pinpoint one single issue that you think is most important, but I want to refine that question somewhat in light of your excellent presentations.

Date

Thu, 08/02/2012

Transcript, Meeting 10, Session 10

SESSION 10: SCIENTIFIC, MEDICAL, AND PUBLIC HEALTH INFORMATION TO FACILITATE DECISION-MAKING FOR PEDIATRIC RESEARCH ON MEDICAL COUNTERMEASURES                            

Date

Thu, 08/02/2012

Transcript, Meeting 10, Session 9

SESSION 9: NATIONAL-LEVEL REVIEW OF PEDIATRIC RESEARCH

DR. GUTMANN:  I am going to get started because we have a wonderful guest.

Please take seats.

Our next session will focus on national-level review of certain types of pediatric research.  Initially contemplated in the late 1970s by one of our predecessor bioethics commissions, the National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research, this type of national-level review is also codified in federal regulations.

Date

Thu, 08/02/2012

Transcript, Meeting 10, Session 8

SESSION 8: ASSESSING PEDIATRIC RESEARCH: CONSIDERING INDIVIDUAL RISK AND SOCIETAL BENEFIT

DR. WAGNER:  Okay.  If we can have the Commissioners take their seats?

And we will begin our Session 8, after a very productive Session 7.  Thank you, Amy.  That was excellent.

And so, at this point in our meeting, we do switch gears.  We have been talking about genomics and whole genomic sequencing.  We are going to shift to medical countermeasures.

Date

Thu, 08/02/2012

Pages

Subscribe to RSS - Medical Countermeasures

This is a work of the U.S. Government and is not subject to copyright protection in the United States. Foreign copyrights may apply.